Cargando…
Artemisinin: A Promising Adjunct for Cancer Therapy
Artemisinin is a herb derived from Artemesia annua (also known as sweet wormwood) and is known for its use as effective antimalarial pharmacotherapy. Recent studies have shown that artemisinin has anti-angiogenic and growth inhibition effects, as well as an apoptotic ability secondary to its inheren...
Autores principales: | Waseem, Yamna, Hasan, Choudhary A, Ahmed, Furqan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6347441/ https://www.ncbi.nlm.nih.gov/pubmed/30697504 http://dx.doi.org/10.7759/cureus.3628 |
Ejemplares similares
-
An Observational Study Comparing the Effects of Chloroquine and Artemisinin-Based Combination Therapy on Hematological Recovery in Patients With Plasmodium vivax Malaria
por: Rao, Sharada Shri, et al.
Publicado: (2023) -
Protocol for a quasi-experimental study to assess the feasibility, acceptability and costs of multiple first-lines artemisinin-based combination therapies for uncomplicated malaria in the Kaya health district, Burkina Faso
por: SIRIBIE, Mohamadou, et al.
Publicado: (2021) -
Adjunctive clindamycin for cellulitis: a clinical trial comparing flucloxacillin with or without clindamycin for the treatment of limb cellulitis
por: Brindle, Richard, et al.
Publicado: (2017) -
Efficacy of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a protocol for systematic review and individual patient data (IPD) meta-analysis
por: Saito, Makoto, et al.
Publicado: (2019) -
Randomised controlled trial for high-dose intravenous zinc as adjunctive therapy in SARS-CoV-2 (COVID-19) positive critically ill patients: trial protocol
por: Perera, Marlon, et al.
Publicado: (2020)